Shuenn‐Chen Yang

549 total citations
13 papers, 442 citations indexed

About

Shuenn‐Chen Yang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Shuenn‐Chen Yang has authored 13 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Shuenn‐Chen Yang's work include Lung Cancer Treatments and Mutations (3 papers), Virus-based gene therapy research (2 papers) and Ubiquitin and proteasome pathways (2 papers). Shuenn‐Chen Yang is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Virus-based gene therapy research (2 papers) and Ubiquitin and proteasome pathways (2 papers). Shuenn‐Chen Yang collaborates with scholars based in Taiwan, United States and Australia. Shuenn‐Chen Yang's co-authors include Pan‐Chyr Yang, Kuo‐Yen Huang, Shih-Han Kao, Tse‐Ming Hong, Zi‐Xian Liao, S.‐Ja Tseng, Ivan M. Kempson, Hsuan‐Yu Chen, Konan Peck and Jeremy J.W. Chen and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and ACS Nano.

In The Last Decade

Shuenn‐Chen Yang

13 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuenn‐Chen Yang Taiwan 9 257 93 74 68 56 13 442
Guangyue Shi China 12 358 1.4× 70 0.8× 61 0.8× 80 1.2× 39 0.7× 31 577
Taichun Qin United States 12 540 2.1× 70 0.8× 52 0.7× 60 0.9× 33 0.6× 15 849
Bingqian Guo China 14 302 1.2× 67 0.7× 99 1.3× 96 1.4× 59 1.1× 27 552
Emanuele Celauro Sweden 8 204 0.8× 71 0.8× 105 1.4× 92 1.4× 15 0.3× 12 451
Cristina Manguán-García Spain 13 383 1.5× 81 0.9× 58 0.8× 57 0.8× 31 0.6× 23 588
Shibo Ying China 16 230 0.9× 63 0.7× 36 0.5× 98 1.4× 73 1.3× 35 549
Maria Mrakovcic Austria 12 347 1.4× 82 0.9× 36 0.5× 27 0.4× 18 0.3× 14 526
Zhi‐Zhong Wu China 16 292 1.1× 99 1.1× 129 1.7× 66 1.0× 129 2.3× 30 596
Xin Wei China 17 317 1.2× 130 1.4× 37 0.5× 26 0.4× 215 3.8× 36 730
Anna Fiszer-Kierzkowska Poland 10 294 1.1× 73 0.8× 28 0.4× 46 0.7× 44 0.8× 17 520

Countries citing papers authored by Shuenn‐Chen Yang

Since Specialization
Citations

This map shows the geographic impact of Shuenn‐Chen Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuenn‐Chen Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuenn‐Chen Yang more than expected).

Fields of papers citing papers by Shuenn‐Chen Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuenn‐Chen Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuenn‐Chen Yang. The network helps show where Shuenn‐Chen Yang may publish in the future.

Co-authorship network of co-authors of Shuenn‐Chen Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Shuenn‐Chen Yang. A scholar is included among the top collaborators of Shuenn‐Chen Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuenn‐Chen Yang. Shuenn‐Chen Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Fang, Jia‐You, Kuo‐Yen Huang, Tong‐Hong Wang, et al.. (2024). Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19. Journal of Nanobiotechnology. 22(1). 169–169. 4 indexed citations
2.
Wang, Tong‐Hong, Kuo‐Yen Huang, Chih‐Cheng Chen, et al.. (2023). PM2 .5 promotes lung cancer progression through activation of the AhR‐TMPRSS2‐IL18 pathway. EMBO Molecular Medicine. 15(6). e17014–e17014. 49 indexed citations
3.
Lin, Chia‐Yi, Kuo‐Yen Huang, Shih-Han Kao, et al.. (2023). Small-molecule PIK-93 modulates the tumor microenvironment to improve immune checkpoint blockade response. Science Advances. 9(14). eade9944–eade9944. 25 indexed citations
4.
Wang, Tong‐Hong, Yann‐Lii Leu, Chih‐Cheng Chen, et al.. (2022). Psorachromene induces apoptosis and suppresses tumor growth in NSCLC cells harboring EGFR L858R/T790M/C797S. Phytotherapy Research. 36(5). 2116–2126. 3 indexed citations
5.
Lai, Wei‐Yun, et al.. (2021). PINK1-Mediated Inhibition of EGFR Dimerization and Activation Impedes EGFR-Driven Lung Tumorigenesis. Cancer Research. 81(7). 1745–1757. 1 indexed citations
6.
Lin, Chia‐Yi, Kuo‐Yen Huang, Yi‐Chun Lin, et al.. (2021). Vorinostat combined with brigatinib overcomes acquired resistance in EGFR-C797S-mutated lung cancer. Cancer Letters. 508. 76–91. 20 indexed citations
7.
8.
Wang, Yating, Jayu Jen, Chun‐Ming Chen, et al.. (2017). Ubiquitination of tumor suppressor PML regulates prometastatic and immunosuppressive tumor microenvironment. Journal of Clinical Investigation. 127(8). 2982–2997. 64 indexed citations
9.
Tseng, S.‐Ja, Kuo‐Yen Huang, Ivan M. Kempson, et al.. (2016). Remote Control of Light-Triggered Virotherapy. ACS Nano. 10(11). 10339–10346. 37 indexed citations
10.
Tseng, S.‐Ja, Zi‐Xian Liao, Shih-Han Kao, et al.. (2015). Highly specific in vivo gene delivery for p53-mediated apoptosis and genetic photodynamic therapies of tumour. Nature Communications. 6(1). 6456–6456. 96 indexed citations
11.
Lai, Wei‐Yun, Chi‐Yuan Chen, Shuenn‐Chen Yang, et al.. (2014). Overcoming EGFR T790M-based Tyrosine Kinase Inhibitor Resistance with an Allele-specific DNAzyme. Molecular Therapy — Nucleic Acids. 3. e150–e150. 3 indexed citations
12.
Lin, Jau‐Chen, Shuenn‐Chen Yang, Tse‐Ming Hong, et al.. (2009). Phenanthrene-Based Tylophorine-1 (PBT-1) Inhibits Lung Cancer Cell Growth through the Akt and NF-κB Pathways. Journal of Medicinal Chemistry. 52(7). 1903–1911. 55 indexed citations
13.
Hong, Tse‐Ming, Pan‐Chyr Yang, Konan Peck, et al.. (2000). Profiling the Downstream Genes of Tumor Suppressor PTEN in Lung Cancer Cells by Complementary DNA Microarray. American Journal of Respiratory Cell and Molecular Biology. 23(3). 355–363. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guangyue Shi Breakdown of academic impact, for papers by Taichun Qin Breakdown of academic impact, for papers by Bingqian Guo Breakdown of academic impact, for papers by Emanuele Celauro Breakdown of academic impact, for papers by Cristina Manguán-García Breakdown of academic impact, for papers by Shibo Ying Breakdown of academic impact, for papers by Maria Mrakovcic Breakdown of academic impact, for papers by Zhi‐Zhong Wu Breakdown of academic impact, for papers by Xin Wei Breakdown of academic impact, for papers by Anna Fiszer-Kierzkowska
Rankless by CCL
2026